Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Myeloid

Explore clinical trials studying Leukemia, Myeloid. Study availability and eligibility vary by location and protocol.

3,104 public trials 618 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Myeloid trial results

Completed

Caspofungin Acetate in Treating Aspergillosis in Patients With Hematologic Cancer or in Patients Who Have Undergone a Stem Cell Transplant

NCT00110045

Conditions
Adnexal Diseases, Amyloidosis, Ataxia, +137 more
Locations
  • CHU Liege - Domaine Universitaire du Sart Tilman Liège, Belgium
  • Centre Hospitalier Universitaire Henri Mondor Créteil, France
  • Hopital Edouard Herriot - Lyon Lyon, France
  • Hopital Saint-Louis Paris, France
View all 13 locations
View Trial Details
Completed

Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell Count

NCT00003805

Conditions
Blast Crisis, Blood Protein Disorders, Body Temperature Changes, +69 more
Locations
  • Marlene & Stewart Greenebaum Cancer Center, University of Maryland Baltimore, Maryland, United States
  • Boston Medical Center Boston, Massachusetts, United States
  • Algemeen Ziekenhuis Middelheim Antwerp, Belgium
  • Hopital Universitaire Erasme Brussels, Belgium
View all 28 locations
View Trial Details
Completed

Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain

NCT00666211

Conditions
Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +108 more
Locations
  • Jennie Stuart Medical Center Hopkinsville, Kentucky, United States
  • Mitchell Memorial Cancer Center at Owensboro Medical Health System Owensboro, Kentucky, United States
  • Erlanger Health System Chattanooga, Tennessee, United States
  • Tennessee Plateau Oncology Crossville, Tennessee, United States
View Trial Details
Completed

Dose Escalation Study of CAL-101 in Select Relapsed or Refractory Hematologic Malignancies

NCT00710528

Conditions
Acute Myeloid Leukemia (AML), Blood Protein Disorders, Cardiovascular Diseases, +29 more
Locations
  • Stanford Cancer Center Palo Alto, California, United States
  • The Sidney Kimmel Comprehensive Cancer Center at John Hopkins Baltimore, Maryland, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Washington University School of Medicine St Louis, Missouri, United States
View Trial Details
Completed

Chemotherapy With or Without Gemtuzumab Ozogamicin in Treating Older Patients With Acute Myeloid Leukemia

NCT00052299

Conditions
Bone Marrow Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +12 more
Locations
  • A. oe. Krankenhaus der Barmherzigen Schwestern Kinderabteilung Linz, Austria
  • Allgemeines Krankenhaus - Universitatskliniken Vienna, Austria
  • AZ Sint-Jan Bruges, Belgium
  • Institut Jules Bordet Brussels, Belgium
View all 55 locations
View Trial Details
Completed

CMA-676 in Treating Patients With Acute Myeloid Leukemia in First Relapse

NCT00003131

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +4 more
Locations
  • Arizona Cancer Center Tucson, Arizona, United States
  • Beckman Research Institute, City of Hope Duarte, California, United States
  • Sylvester Cancer Center, University of Miami Miami, Florida, United States
  • University of Chicago Cancer Research Center Chicago, Illinois, United States
View all 13 locations
View Trial Details
Completed

CMA-676 in Treating Older Patients With Acute Myeloid Leukemia in First Relapse

NCT00003673

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +4 more
Locations
  • Arizona Cancer Center Tucson, Arizona, United States
  • Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States
  • Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States
  • University of Chicago Cancer Research Center Chicago, Illinois, United States
View Trial Details

Related conditions